Shares last traded at $32.30 a tad above $29.21, the 50 day moving average and a tad higher than the 200 day moving average of $26.76. The 50 day moving average was up $3.09 or +10.58% and the 200 day average went up by +20.69%. Trading volume for BioTelemetry, Inc. was 268K on Thursday. Volume was down 39.07% under the stocks average daily volume.
Investors are a little more bearish on shares of BioTelemetry, Inc. recently if you consider the uptick in short interest. The firm realized a rise in short interest of 34.50% as of May 31, 2017 from the last reporting period. Short interest increased from 1,238,821 to 1,666,260 over that period. With short interest at 1,666,260 and short average daily volume at 478,802, days to cover is 3.5 and the short interest percentage is 0.06% as of May 31.
There has been some selling insider activity on BioTelemetry, Inc. (NASDAQ:BEAT) recently. SVP – Sales Marketing Fred Broadway sold 3,429 shares at an average price of $26.90 on March 20th. The SVP – Sales Marketing now owns $683,798 of the stock as recorded in a recent Form 4 SEC filing. Sr VP George Hrenko sold 126,043 shares at an average price of $25.95 on Mon the 27th. That brings the Sr VP’s holdings to $532,442 as reported to the SEC.
Fred Broadway, SVP – Sales Marketing let go of $200,217 worth of shares at an average price of $24.81 on Tue the 21st. Broadway now owns $715,744 of stock per an SEC filing yesterday.
Here are a few other firms who have also updated their positions. Morgan Stanley grew its position by buying 457 shares an increase of 304.7% as of 03/31/2017. Morgan Stanley claims 607 shares with a value of $18,000. The value of the position overall is up by 500.0%. As of quarter end Goldman Sachs Group Inc had disposed of a total of 91,085 shares trimming its position 88.0%. The value of the investment in BEAT went from $2,313,000 to $359,000 decreasing 84.5% quarter to quarter.
Driehaus Capital Management LLC added to its investment by buying 85,386 shares an increase of 53.5% in the quarter. Driehaus Capital Management LLC now holds 244,866 shares worth $7,089,000. The total value of its holdings increased 98.9%. As of the end of the quarter State Street Corp had bought 32,124 shares growing its position 4.6%. The value of the investment in BEAT increased from $15,771,000 to $21,356,000 increasing 35.4% since the last quarter.
Equity analyst Benchmark began coverage of the stock by announcing an initial rating of “Buy”. On December 2, 2016 Dougherty starting coverage on the stock giving it an initial rating of “Buy”.
On September 13 analysts at Sidoti & Co. started coverage setting a rating of “Buy”. On November 24, 2014 the stock rating was changed to a “Outperform” by Avondale Partners a boost from the previous “Market Perform” rating.
The company is up since yesterday’s close of $31.95. The company currently has a P/E ratio of 20.17 and market cap is 925.56M. As of the latest earnings report the EPS was $1.60 and is projected to be $0.89 for the current year with 28,655,000 shares outstanding. Analysts expect next quarter’s EPS to be $0.24 and the next full year EPS is anticipated to be $1.16.
BioTelemetry, Inc., launched on April 12, 2013, provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates through three segments: Healthcare, Technology and Research..